title: Chondrogenic phenotype of articular chondrocytes in monoculture and co-culture with mesenchymal stem cells in flow perfusion.
abstract: This work investigated the effect of flow perfusion bioreactor culture with and without transforming growth factor-β3 (TGF-β3) supplementation on the proliferation, extracellular matrix (ECM) production, and chondrogenic gene expression of chondrocytes both in monoculture and in co-culture with bone marrow-derived mesenchymal stem cells (MSCs). Both cell populations were cultured on electrospun poly(ɛ-caprolactone) scaffolds for 2 weeks in static or flow perfusion culture with and without TGF-β3. Overall, it was observed that without growth factors, flow perfusion culture resulted in increased cell proliferation and ECM with a more cartilage-like composition. While with TGF-β3 induction, flow perfusion constructs generally had lower chondrogenic gene expression than the corresponding static cultures, the growth factor still had an inductive effect on the cells with enhanced gene expression compared with the corresponding noninduced cultures. In addition, while flow perfusion cultures generally had reduced overall ECM content, the ECM distribution was more homogenous compared with the corresponding static cultures. These results are significant in that they indicate that while flow perfusion culture has some beneficial effects on the chondrogenic phenotype of articular chondrocytes, flow perfusion alone is not sufficient to maintain the chondrogenic phenotype of chondrocytes in either monoculture or co-culture, thus demonstrating the advantages of using exogenously added growth factors in flow perfusion culture. Furthermore, the results demonstrate the advantages of flow perfusion culture for the creation of large tissue engineered constructs and the potential of co-cultures of articular chondrocytes and MSCs to be used in flow perfusion culture.
authors.affiliation: Department of Bioengineering, Rice University , Houston, Texas.
authors.forename: Rebecca L
authors.initials: RL
authors.lastname: Dahlin
authors.forename: Ville V
authors.initials: VV
authors.lastname: Meretoja
authors.forename: Mengwei
authors.initials: M
authors.lastname: Ni
authors.forename: F Kurtis
authors.initials: FK
authors.lastname: Kasper
authors.forename: Antonios G
authors.initials: AG
authors.lastname: Mikos
mesh_terms: D000818:Animals; D002358:Cartilage, Articular / Q000166:cytology* / Q000187:drug effects / Q000254:growth & development; D002417:Cattle; D049109:Cell Proliferation / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology* / Q000187:drug effects / Q000502:physiology; D020219:Chondrogenesis / Q000187:drug effects / Q000502:physiology; D018920:Coculture Techniques / Q000379:methods*; D004867:Equipment Design; D019544:Equipment Failure Analysis; D036341:Intercellular Signaling Peptides and Proteins / Q000494:pharmacology; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000187:drug effects / Q000502:physiology; D010477:Perfusion / Q000295:instrumentation / Q000379:methods; D010641:Phenotype; D011817:Rabbits; D023822:Tissue Engineering / Q000295:instrumentation*; D054457:Tissue Scaffolds; D053782:Transforming Growth Factor beta3 / Q000494:pharmacology*
chemical_list: D036341:Intercellular Signaling Peptides and Proteins; D053782:Transforming Growth Factor beta3
references.citation: Biomacromolecules. 2006 Oct;7(10):2796-805
references.pmid: 17025355
references.citation: Biotechnol Prog. 2000 Sep-Oct;16(5):893-6
references.pmid: 11027186
references.citation: Biorheology. 2006;43(3,4):215-22
references.pmid: 16912395
references.citation: Cell. 1982 Aug;30(1):215-24
references.pmid: 7127471
references.citation: Tissue Eng. 2006 Mar;12(3):469-79
references.pmid: 16579680
references.citation: Biomaterials. 2014 Jan;35(1):123-32
references.pmid: 24125773
references.citation: Nat Protoc. 2008;3(6):1101-8
references.pmid: 18546601
references.citation: PLoS One. 2011;6(8):e23119
references.pmid: 21858004
references.citation: Tissue Eng Part C Methods. 2012 Oct;18(10):817-20
references.pmid: 22468910
references.citation: Biomaterials. 2013 Jun;34(17):4266-73
references.pmid: 23489925
references.citation: Acta Orthop. 2011 Apr;82(2):234-40
references.pmid: 21434761
references.citation: Ann Biomed Eng. 2014 Jul;42(7):1381-90
references.pmid: 23842695
references.citation: Biomaterials. 2010 Aug;31(24):6279-308
references.pmid: 20493521
references.citation: Tissue Eng Part C Methods. 2014 Jun;20(6):514-23
references.pmid: 24387702
references.citation: Biomaterials. 2000 Mar;21(5):431-40
references.pmid: 10674807
references.citation: Biomaterials. 2012 Sep;33(27):6362-9
references.pmid: 22695067
references.citation: Tissue Eng. 2003 Jun;9(3):549-54
references.pmid: 12857422
references.citation: Tissue Eng. 2002 Aug;8(4):581-90
references.pmid: 12201998
references.citation: Cancer Res. 1986 Jul;46(7):3513-20
references.pmid: 3708583
references.citation: Biorheology. 2004;41(3-4):401-10
references.pmid: 15299272
references.citation: J Biomed Mater Res. 2001 Sep 5;56(3):368-75
references.pmid: 11372054
references.citation: Biomaterials. 2010 Dec;31(34):8911-20
references.pmid: 20797784
references.citation: Tissue Eng. 2002 Oct;8(5):807-16
references.pmid: 12459059
references.citation: Biorheology. 2008;45(3-4):471-8
references.pmid: 18836246
references.citation: J Orthop Sports Phys Ther. 1998 Oct;28(4):203-15
references.pmid: 9785256